543 related articles for article (PubMed ID: 21644036)
1. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.
Gabitass RF; Annels NE; Stocken DD; Pandha HA; Middleton GW
Cancer Immunol Immunother; 2011 Oct; 60(10):1419-30. PubMed ID: 21644036
[TBL] [Abstract][Full Text] [Related]
2. Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy.
Mundy-Bosse BL; Young GS; Bauer T; Binkley E; Bloomston M; Bill MA; Bekaii-Saab T; Carson WE; Lesinski GB
Cancer Immunol Immunother; 2011 Sep; 60(9):1269-79. PubMed ID: 21604071
[TBL] [Abstract][Full Text] [Related]
3. CD45
Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
[TBL] [Abstract][Full Text] [Related]
4. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.
Garg A; Spector SA
J Infect Dis; 2014 Feb; 209(3):441-51. PubMed ID: 23999600
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
Lechner MG; Liebertz DJ; Epstein AL
J Immunol; 2010 Aug; 185(4):2273-84. PubMed ID: 20644162
[TBL] [Abstract][Full Text] [Related]
6. Circulating myeloid-derived suppressor cells in patients with pancreatic cancer.
Xu XD; Hu J; Wang M; Peng F; Tian R; Guo XJ; Xie Y; Qin RY
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):99-105. PubMed ID: 26818550
[TBL] [Abstract][Full Text] [Related]
7. Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease.
Markowitz J; Brooks TR; Duggan MC; Paul BK; Pan X; Wei L; Abrams Z; Luedke E; Lesinski GB; Mundy-Bosse B; Bekaii-Saab T; Carson WE
Cancer Immunol Immunother; 2015 Feb; 64(2):149-59. PubMed ID: 25305035
[TBL] [Abstract][Full Text] [Related]
8. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
9. Infiltration of alternatively activated macrophages in cancer tissue is associated with MDSC and Th2 polarization in patients with esophageal cancer.
Gao J; Wu Y; Su Z; Amoah Barnie P; Jiao Z; Bie Q; Lu L; Wang S; Xu H
PLoS One; 2014; 9(8):e104453. PubMed ID: 25144454
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.
Raychaudhuri B; Rayman P; Ireland J; Ko J; Rini B; Borden EC; Garcia J; Vogelbaum MA; Finke J
Neuro Oncol; 2011 Jun; 13(6):591-9. PubMed ID: 21636707
[TBL] [Abstract][Full Text] [Related]
12. IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
Chen MF; Kuan FC; Yen TC; Lu MS; Lin PY; Chung YH; Chen WC; Lee KD
Oncotarget; 2014 Sep; 5(18):8716-28. PubMed ID: 25238263
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells.
Weide B; Martens A; Zelba H; Stutz C; Derhovanessian E; Di Giacomo AM; Maio M; Sucker A; Schilling B; Schadendorf D; Büttner P; Garbe C; Pawelec G
Clin Cancer Res; 2014 Mar; 20(6):1601-9. PubMed ID: 24323899
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
[TBL] [Abstract][Full Text] [Related]
15. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins.
Wang L; Chang EW; Wong SC; Ong SM; Chong DQ; Ling KL
J Immunol; 2013 Jan; 190(2):794-804. PubMed ID: 23248262
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
17. Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer.
Jiao ZJ; Gao JJ; Hua SH; Chen DY; Wang WH; Wang H; Wang XH; Xu HX
World J Gastroenterol; 2012 Oct; 18(38):5454-61. PubMed ID: 23082063
[TBL] [Abstract][Full Text] [Related]
18. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.
Mace TA; Ameen Z; Collins A; Wojcik S; Mair M; Young GS; Fuchs JR; Eubank TD; Frankel WL; Bekaii-Saab T; Bloomston M; Lesinski GB
Cancer Res; 2013 May; 73(10):3007-18. PubMed ID: 23514705
[TBL] [Abstract][Full Text] [Related]
20. Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.
Arihara F; Mizukoshi E; Kitahara M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
Cancer Immunol Immunother; 2013 Aug; 62(8):1421-30. PubMed ID: 23764929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
